Results of a worldwide external quality assessment of cfDNA testing in lung Cancer

BACKGROUND: Circulating cell free DNA (cfDNA) testing of plasma for EGFR somatic variants in lung cancer patients is being widely implemented and with any new service, external quality assessment (EQA) is required to ensure patient safety. An international consortium, International Quality Network f...

Descripción completa

Detalles Bibliográficos
Autores principales: Fairley, Jennifer A., Cheetham, Melanie H., Patton, Simon J., Rouleau, Etienne, Denis, Marc, Dequeker, Elisabeth M. C., Schuuring, Ed, van Casteren, Kaat, Fenizia, Francesca, Normanno, Nicola, Deans, Zandra C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275131/
https://www.ncbi.nlm.nih.gov/pubmed/35820813
http://dx.doi.org/10.1186/s12885-022-09849-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275131/
https://www.ncbi.nlm.nih.gov/pubmed/35820813
http://dx.doi.org/10.1186/s12885-022-09849-x

Ejemplares similares